Sector News

Agfa HealthCare acquires TIP Group

January 12, 2016
Life sciences

Agfa HealthCare announces today, that it has acquired the TIP Group, which is based in Graz, Austria. This merger of two healthcare pioneers will broaden Agfa HealthCare’s portfolio with specialized Business Intelligence and ERP solutions for hospitals.

Specialized tools for Business Intelligence
“The merger with the TIP Group will give us access to a specialist in hospital Business Intelligence, with solutions that will extend our global offering in a meaningful way,” says Winfried Post, CEO and General Manager, Agfa HealthCare GmbH. “Business Intelligence solutions are ever-more important for hospitals. The increasing cost pressures in healthcare will only be efficiently managed in the future using specialized tools. With this acquisition, we now have a solution that is tailored to the data integration and analysis needs of the hospital, allowing us to generate an even higher added value for healthcare facilities.”

Agfa HealthCare (agfahealthcare.com) and the TIP Group (tip-ag.com) both have long-standing experience in healthcare and in the optimization of processes. Combined with deep insight into hospital workflows, this will enable the advantages of a joint future will be realized quickly, and an extremely powerful team will emerge from the merger.

Extended portfolio of solutions
“The acquisition by Agfa HealthCare opens up new possibilities for our comprehensive product portfolio,” says Heimo Babcicky, chairman and founder of the TIP Group. “Agfa HealthCare is a strong and solid partner for us and for our customers, which enables us to jointly offer a larger portfolio. In this way, our solutions improve and our customers benefit from our cooperation.”

The new partners will begin working together immediately, to mutually make the change for a successful future.

Source: Agfa HealthCare

Related News

May 1, 2021

AbbVie remains one of the best buys in its sector

Life sciences

AbbVie will be among the stocks closing out a busy earnings week. Earnings season tends to draw a lot of interest from investors, but it’s not always the best indicator of a stock’s overall trajectory.

May 1, 2021

Pfizer buys infectious disease biotech Amplyx

Life sciences

Pfizer has bought privately held Amplyx Pharmaceuticals for an undisclosed sum, gaining experimental antifungal and antiviral treatments as the world’s attention turns more toward infectious diseases.

May 1, 2021

Medtronic taps virtual reality ‘flight simulators’ for brain surgery, built from 3D patient scans

Life sciences

Surgical Theater’s technology builds 3D models of an individual patient’s anatomy from CT and MRI scans to offer surgeons an immersive, 360-degree fly-through view.

Send this to a friend